In 2016 while completing my law degree in Jamaica, I had a unique and strange headache. The pain was on and off, but the headache seemed to center around my eyes. As a busy student, I chose to ignore it....
Read More »
In my personal experience with having glaucoma and being visually impaired, at some point in my life, I will have to use Braille. When I was a young child, I thought that Braille didn’t apply to me and it was...
Read More »
Glaucoma is a worldwide problem that can lead to blindness. It is especially problematic because there are often no symptoms in its early stages and although certain groups are at higher risk than others, everyone, at any age, is at...
Read More »
Glaucoma, the leading cause of irreversible blindness, is a complicated disease in which damage to the optic nerve leads to progressive vision loss. Today, more than 3 million Americans are living with glaucoma, and this number is expected to double...
Read More »
More than 50 companies and institutions were featured during a full day of presentations, panels, and discussions with leaders from start-up companies, industry executives, ophthalmic experts, venture capitalists, and the FDA.
Read More »
Whenever a new Apple product is released, the media hype is immense and people will camp out for days just to be the first to own one. Ophthalmology is never going to be as interesting as iPhones but in our...
Read More »
Robert N. Shaffer, MD founded Glaucoma Research Foundation in 1978. He was a pioneer in the field of glaucoma and an outstanding teacher and mentor to young doctors. His proudest professional accomplishment was the establishment of the annual Shaffer Fellowship...
Read More »
Glaucoma Research Foundation will be hosting Glaucoma 360 New Horizons Forum in San Francisco on February 9, 2018. Now in its 7th year, this unique meeting highlights promising and innovative advances in glaucoma and unites clinicians with leaders in medicine,...
Read More »
When Roberta Kameda took her daughter Samantha to a routine eye exam, an optometrist noticed she had high pressure in one of her eyes. Samantha was only in the 8th grade. When she was diagnosed with glaucoma, it was a...
Read More »
Andrew D. Huberman, PhD, a neuroscientist at Stanford University, is a member of the Catalyst for a Cure Biomarker Initiative. This unique consortium of four scientists is working collaboratively to develop new, specific and sensitive biomarkers to diagnose and manage...
Read More »
